{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:32:56Z","timestamp":1763037176184,"version":"3.41.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,3,26]],"date-time":"2018-03-26T00:00:00Z","timestamp":1522022400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s10822-018-0113-2","type":"journal-article","created":{"date-parts":[[2018,3,26]],"date-time":"2018-03-26T06:34:08Z","timestamp":1522046048000},"page":"573-582","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["In-silico guided discovery of novel CCR9 antagonists"],"prefix":"10.1007","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3652-292X","authenticated-orcid":false,"given":"Xin","family":"Zhang","sequence":"first","affiliation":[]},{"given":"Jason B.","family":"Cross","sequence":"additional","affiliation":[]},{"given":"Jan","family":"Romero","sequence":"additional","affiliation":[]},{"given":"Alexander","family":"Heifetz","sequence":"additional","affiliation":[]},{"given":"Eric","family":"Humphries","sequence":"additional","affiliation":[]},{"given":"Katie","family":"Hall","sequence":"additional","affiliation":[]},{"given":"Yuchuan","family":"Wu","sequence":"additional","affiliation":[]},{"given":"Sabrina","family":"Stucka","sequence":"additional","affiliation":[]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[]},{"given":"Haoqun","family":"Chandonnet","sequence":"additional","affiliation":[]},{"given":"Blaise","family":"Lippa","sequence":"additional","affiliation":[]},{"given":"M. Dominic","family":"Ryan","sequence":"additional","affiliation":[]},{"given":"J. Christian","family":"Baber","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2018,3,26]]},"reference":[{"key":"113_CR1","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1053\/gast.2001.27154","volume":"121","author":"KA Papadakis","year":"2001","unstructured":"Papadakis KA, Prehn J, Moreno ST et al (2001) CCR-9 positive lymphocytes and thymus-expressed chemokine distinguish small bowel from colonic Crohn\u2019s disease. Gastroenterology 121:246\u2013254","journal-title":"Gastroenterology"},{"key":"113_CR2","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1124\/jpet.110.169714","volume":"335","author":"MJ Walters","year":"2010","unstructured":"Walters MJ, Wang Y, Lai N, Baumgart T, Zhao BN, Dairaghi DJ, Bekker P, Ertl LS, Penfold ME, Jaen JC, Keshav S, Wendt E, Pennell A, Ungashe S, Wei Z, Wright JJ, Schall TJ (2010) Characterization of CCX282-B, an orally bioavailable antagonist of the CCR9 chemokine receptor, for treatment of inflammatory bowel disease. J Pharmacol Exp Ther 335:61\u201369","journal-title":"J Pharmacol Exp Ther"},{"issue":"7","key":"113_CR3","first-page":"472","volume":"13","author":"E Bertus","year":"2010","unstructured":"Bertus E, David H, Adams (2010) GSK-1605786, a selective small-molecule antagonist of the CCR9 chemokine receptor for the treatment of Crohn\u2019s disease. IDrugs 13(7):472\u2013481 (Thomson Reuters)","journal-title":"IDrugs"},{"key":"113_CR4","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1021\/jm200568c","volume":"55","author":"WT Choi","year":"2012","unstructured":"Choi WT (2012) J. Drug discovery research targeting the CXC chemokine receptor 4 (CXCR4). J Med Chem 55:977\u2013994","journal-title":"J Med Chem"},{"key":"113_CR5","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/nature20606","volume":"540","author":"C Oswald","year":"2016","unstructured":"Oswald C et al (2016) Intracellular allosteric antagonism of the CCR9 receptor. Nature 540:462\u2013465","journal-title":"Nature"},{"key":"113_CR6","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/S0167-5699(99)01469-3","volume":"20","author":"A Mantovani","year":"1999","unstructured":"Mantovani A (1999) The chemokine system: redundancy for robust outputs. Immunol Today 20:254\u2013257","journal-title":"Immunol Today"},{"key":"113_CR7","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/exd.12709","volume":"24","author":"PM Brunner","year":"2015","unstructured":"Brunner PM, Glitzner E, Reininger B et al (2015) CCL7 contributes to the TNF-alpha-dependent inflammation of lesional psoriatic skin. Exp Dermatol 24:522\u2013528","journal-title":"Exp Dermatol"},{"key":"113_CR8","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1146\/annurev.immunol.24.021605.090529","volume":"25","author":"SJ Allen","year":"2007","unstructured":"Allen SJ, Crown SE, Handel TM (2007) Chemokine: receptor structure, interactions, and antagonism. Annu Rev Immunol 25:787\u2013820","journal-title":"Annu Rev Immunol"},{"key":"113_CR9","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0031-6997(24)01439-X","volume":"52","author":"PM Murphy","year":"2000","unstructured":"Murphy PM, Baggiolini M, Charo IF, H\u00e9bert CA, Horuk R, Matsushima K, Miller LH, Oppenheim JJ, Power CA (2000) International Union of Pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol Rev 52:145\u2013176","journal-title":"Pharmacol Rev"},{"key":"113_CR10","unstructured":"Ungashe S, Wei Z, Basak A, Charvat T, Jin J, Moore J, Zang Y, Punna S, Dairaghi D, Hansen D, Pennell A (2006) Heteroaryl Sulfonamides and CCR2. U.S. Patent 20060173019 A1, 3 August 2006"},{"issue":"22","key":"113_CR11","doi-asserted-by":"publisher","first-page":"9363","DOI":"10.1021\/jm300682j","volume":"55","author":"James Pease; Richard Horuk Chemokine Receptor Antagonists","year":"2012","unstructured":"James Pease; Richard Horuk Chemokine Receptor Antagonists (2012) J Med Chem 55(22):9363\u20139392","journal-title":"J Med Chem"},{"key":"113_CR12","doi-asserted-by":"publisher","first-page":"4584","DOI":"10.1128\/AAC.49.11.4584-4591.2005","volume":"49","author":"M Baba","year":"2005","unstructured":"Baba M, Takashima K, Miyake H, Kanzaki N, Teshima K, Wang X, Shiraishi M, Iizawa Y (2005) TAK-652 inhibits CCR5-mediated human immunodeficiency virus type 1 infection in vitro and has favorable pharmacokinetics in humans. Antimicrob Agents Chemother 49:4584\u20134591","journal-title":"Antimicrob Agents Chemother"},{"key":"113_CR13","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1021\/jm00120a002","volume":"31","author":"BE Evans","year":"1988","unstructured":"Evans BE, Rittle KE, Bock MG, DiPardo RM, Freidinger RM, Whitter WL, Lundell GF, Veber DF, Anderson PS, Chang RSL, Lotti VJ, Cerino DJ, Chen TB, Kling PJ, Kunkel KA, Springer JP, Hirshfieldt J (1988) Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists. J Med Chem 31:2235","journal-title":"J Med Chem"},{"key":"113_CR14","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/S0065-7743(00)35027-8","volume":"35","author":"AA Patchett","year":"2000","unstructured":"Patchett AA, Nargund RP (2000) Privileged structures\u2014an update. Annu Rep Med Chem 35:289\u2013298","journal-title":"Annu Rep Med Chem"},{"key":"113_CR15","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.1016\/j.bmcl.2015.06.046","volume":"25","author":"J Zhang","year":"2015","unstructured":"Zhang J et al (2015) Biarylsulfonamide CCR9 inhibitors for inflammatory bowel disease. Bioorg Med Chem Lett 25:3661\u20133664","journal-title":"Bioorg Med Chem Lett"},{"key":"113_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1021\/ci300547g","volume":"53","author":"P Willett","year":"2013","unstructured":"Willett P (2013) Combination of similarity rankings using data fusion. J Chem Inf Model 53:1\u201310","journal-title":"J Chem Inf Model"},{"key":"113_CR17","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1002\/cmdc.200800129","volume":"3","author":"L Tan","year":"2008","unstructured":"Tan L, Geppert H, Sisay MT, G\u00fctschow M, Bajorath J (2008) Integrating structure- and ligand-based virtual screening: comparison of individual, parallel, and fused molecular docking and similarity search calculations on multiple targets. ChemMedChem 3:1566\u20131571","journal-title":"ChemMedChem"},{"key":"113_CR18","unstructured":"ChEMBL; ChEMBL database version 13. https:\/\/www.ebi.ac.uk\/chembl\/ . Accessed 18 June 2012"},{"key":"113_CR19","unstructured":"GVK Biosciences; GOSTAR Online Structure Activity Relationship Database. https:\/\/gostardb.com\/gostar\/ . Accessed 5 July 2012"},{"key":"113_CR20","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1021\/ci970429i","volume":"38","author":"XQ Lewell","year":"1998","unstructured":"Lewell XQ, Judd DB, Watson SP, Hann MM (1998) RECAP-retrosynthetic combinatorial analysis procedure: a powerful new technique for identifying privileged molecular fragments with useful applications in combinatorial chemistry. J Chem Inf Comput Sci 38:511\u2013522","journal-title":"J Chem Inf Comput Sci"},{"key":"113_CR21","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1021\/jm9602928","volume":"39","author":"GW Bemis","year":"1996","unstructured":"Bemis GW, Murcko MA (1996) The properties of known drugs. 1. Molecular frameworks. J Med Chem 39:2887\u20132893","journal-title":"J Med Chem"},{"key":"113_CR22","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1021\/ci100050t","volume":"50","author":"D Rogers","year":"2010","unstructured":"Rogers D, Hahn M (2010) Extended-connectivity fingerprints. J Chem Inf Model 50:742\u2013754","journal-title":"J Chem Inf Model"},{"key":"113_CR23","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1002\/cmdc.200800408","volume":"4","author":"Y Hu","year":"2009","unstructured":"Hu Y, Lounkine E, Bajorath J (2009) Improving the search performance of extended connectivity fingerprints through activity-oriented feature filtering and application of a bit-density-dependent similarity function. ChemMedChem 4:540\u2013548","journal-title":"ChemMedChem"},{"issue":"\/24","key":"113_CR24","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.drudis.2006.10.005","volume":"11","author":"P Willet","year":"2006","unstructured":"Willet P (2006) Similarity-based virtual screening using 2D fingerprints. Drug Discov Today 11(23\/24):1046\u20131053","journal-title":"Drug Discov Today"},{"key":"113_CR25","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1021\/ci100031x","volume":"50","author":"PCD Hawkins","year":"2010","unstructured":"Hawkins PCD, Skillman AG, Warren GL, Ellingson BA, Stahl MT (2010) Conformer generation with OMEGA: algorithm and validation using high quality structures from the protein databank and Cambridge structural database. J Chem Inf Model 50:572\u2013584","journal-title":"J Chem Inf Model"},{"key":"113_CR26","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1021\/jm0603365","volume":"50","author":"PCD Hawkins","year":"2007","unstructured":"Hawkins PCD, Skillman AG, Nicholls A (2007) Comparison of shape-matching and docking as virtual screening tools. J Med Chem 50:74\u201382","journal-title":"J Med Chem"},{"key":"113_CR27","doi-asserted-by":"publisher","first-page":"3172","DOI":"10.1039\/B517914A","volume":"8","author":"Y Shao","year":"2006","unstructured":"Shao Y et al (2006) Advances in methods and algorithms in a modern quantum chemistry program package. Phys Chem Chem Phys 8:3172\u20133191","journal-title":"Phys Chem Chem Phys"},{"key":"113_CR28","unstructured":"Molecular Operating Environment (MOE) Chemical Computing Group Inc., 1010 Sherbrooke St. West, Suite #910. Montreal, QC, Canada H3A 2R7"},{"key":"113_CR29","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1126\/science.1194396","volume":"330","author":"B Wu","year":"2010","unstructured":"Wu B et al (2010) Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists. Science 330:1066\u20131071","journal-title":"Science"},{"key":"113_CR30","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/S1043-9471(05)80049-7","volume":"25","author":"JA Ballesteros","year":"1995","unstructured":"Ballesteros JA, Weinstein H (1995) Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors. Methods Neurosci 25:366\u2013428","journal-title":"Methods Neurosci"},{"key":"113_CR31","doi-asserted-by":"publisher","first-page":"36577","DOI":"10.1074\/jbc.M206223200","volume":"277","author":"C Prioleau","year":"2002","unstructured":"Prioleau C, Visiers I, Ebersole BJ, Weinstein H, Sealfon SC (2002) Conserved Helix 7 tyrosine acts as a multistate conformational switch in the 5HT2C receptor identification of a novel \u201clocked-on\u201d phenotype and double revertant mutations. J Biol Chem 277:36577\u201336584","journal-title":"J Biol Chem"},{"key":"113_CR32","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1002\/jcc.21894","volume":"32","author":"B Courcot","year":"2011","unstructured":"Courcot B, Bridgeman AJ (2011) Modeling the interactions between polyoxometalates and their environment. J Comp Chem 32:3143\u20133153","journal-title":"J Comp Chem"},{"key":"113_CR33","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.tips.2007.06.003","volume":"28","author":"BK Kobilka","year":"2007","unstructured":"Kobilka BK, Deupi X (2007) Conformational complexity of G-protein-coupled receptors. Trends Pharmacol Sci 28:397\u2013406","journal-title":"Trends Pharmacol Sci"},{"key":"113_CR34","doi-asserted-by":"crossref","unstructured":"Heifetz A et al (2015) GPCR structure, function, drug discovery and crystallography: Report from Academia-Industry International Conference (UK Royal Society) Chicheley Hall, 1\u20132 September 2014 Naunyn-Schmiedeberg\u2019s archives of pharmacology","DOI":"10.1007\/s00210-015-1111-8"},{"key":"113_CR35","doi-asserted-by":"publisher","first-page":"8246","DOI":"10.1021\/bi401119m","volume":"52","author":"A Heifetz","year":"2013","unstructured":"Heifetz A, Barker O, Morris GB, Law RJ, Slack M, Biggin PC (2013) Toward an understanding of agonist binding to human Orexin-1 and Orexin-2 receptors with G-protein-coupled receptor modeling and site-directed mutagenesis. Biochemistry 52:8246\u20138260","journal-title":"Biochemistry"},{"issue":"12","key":"113_CR36","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1021\/ml200199c","volume":"2","author":"C Xue","year":"2011","unstructured":"Xue C et al (2011) Discovery of INCB8761\/PF-4136309, a potent, selective, and orally bioavailable CCR2 antagonist. ACS Med Chem Lett 2(12):913\u2013918","journal-title":"ACS Med Chem Lett"},{"key":"113_CR37","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/978-1-4939-2914-6_17","volume":"1335","author":"Beuming","year":"2015","unstructured":"Beuming et al (2015) Docking and virtual screening strategies for GPCR drug discovery. Methods Mol Biol 1335:251\u2013276","journal-title":"Methods Mol Biol"},{"key":"113_CR38","doi-asserted-by":"publisher","first-page":"28288","DOI":"10.1038\/srep28288","volume":"6","author":"Kooistra","year":"2016","unstructured":"Kooistra et al (2016) Function-specific virtual screening for GPCR ligands using a combined scoring method. Sci Rep 6:28288","journal-title":"Sci Rep"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-018-0113-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10822-018-0113-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-018-0113-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T23:59:25Z","timestamp":1751500765000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10822-018-0113-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,26]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["113"],"URL":"https:\/\/doi.org\/10.1007\/s10822-018-0113-2","relation":{},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"type":"print","value":"0920-654X"},{"type":"electronic","value":"1573-4951"}],"subject":[],"published":{"date-parts":[[2018,3,26]]},"assertion":[{"value":"29 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}